A progress report on cooperative working groups for improving efficiency of clinical trials for new drug development (Chiken)

Mariko Taniguchi, Masayoshi Nakabayashi, Ichiro Oshiba, Satoshi Sugihara, Shuhei Nobutani, Yoshihiko Kobayashi, Kurumi Ohashi

Research output: Contribution to journalReview article

Abstract

In April 2012, the Chiken(clinical study for drug application)Promotion Committee of Osaka Pharmaceutical Manufacturers Association(OPMA)and Osaka Clinical Research Collaborative Network(OCRCN)organized three Working Groups(WG)composed of clinical research coordinators(CRCs)and clinical research associates(CRAs) to discuss the improvement of the efficiency of Chiken execution. Each group had regular monthly meetings for one and a half years. The firstWG focused on the current understanding and treatment of "source data/document. " It is revealed that a so-called "work sheet" is widely used to record clinical data/comments in Chiken;data /comments are directly recorded on Case Report Forms(CRFs)only in around 50% of the cases. The second WG focused on the method to develop a more intelligible protocol in order to avoid misunderstanding of a protocol by clinical trial sites. It is agreed that a protocol should be developed that further reflects the actual work process of Chiken in a clinical site, and that more detailed explanations of the execution process in a protocol should be helpful. The third WG focused on "standardization of checklist for both clinical sites and study sponsors", covering the selection of clinical trial sites and execution of clinical trial agreements. It is also recognized that the checklist, apart from the original purpose of increasing the efficiency of the execution of clinical trials, is expected to be used as a training tool for beginners. After completing all tasks, a survey was made to assess this activity. Most of the members expressed positive opinions on this project, and the activity to develop a standardized checklist is on-going.

Original languageEnglish
Pages (from-to)127-132
Number of pages6
JournalJapanese Journal of Clinical Pharmacology and Therapeutics
Volume46
Issue number3
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Checklist
Clinical Trials
Pharmaceutical Preparations
Research
Information Storage and Retrieval
Clinical Studies

Keywords

  • Checklist
  • Cooperative working group
  • Protocol
  • Source document

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

A progress report on cooperative working groups for improving efficiency of clinical trials for new drug development (Chiken). / Taniguchi, Mariko; Nakabayashi, Masayoshi; Oshiba, Ichiro; Sugihara, Satoshi; Nobutani, Shuhei; Kobayashi, Yoshihiko; Ohashi, Kurumi.

In: Japanese Journal of Clinical Pharmacology and Therapeutics, Vol. 46, No. 3, 2015, p. 127-132.

Research output: Contribution to journalReview article

Taniguchi, Mariko ; Nakabayashi, Masayoshi ; Oshiba, Ichiro ; Sugihara, Satoshi ; Nobutani, Shuhei ; Kobayashi, Yoshihiko ; Ohashi, Kurumi. / A progress report on cooperative working groups for improving efficiency of clinical trials for new drug development (Chiken). In: Japanese Journal of Clinical Pharmacology and Therapeutics. 2015 ; Vol. 46, No. 3. pp. 127-132.
@article{df91ebe2508843bf97538bbdd9460c1b,
title = "A progress report on cooperative working groups for improving efficiency of clinical trials for new drug development (Chiken)",
abstract = "In April 2012, the Chiken(clinical study for drug application)Promotion Committee of Osaka Pharmaceutical Manufacturers Association(OPMA)and Osaka Clinical Research Collaborative Network(OCRCN)organized three Working Groups(WG)composed of clinical research coordinators(CRCs)and clinical research associates(CRAs) to discuss the improvement of the efficiency of Chiken execution. Each group had regular monthly meetings for one and a half years. The firstWG focused on the current understanding and treatment of {"}source data/document. {"} It is revealed that a so-called {"}work sheet{"} is widely used to record clinical data/comments in Chiken;data /comments are directly recorded on Case Report Forms(CRFs)only in around 50{\%} of the cases. The second WG focused on the method to develop a more intelligible protocol in order to avoid misunderstanding of a protocol by clinical trial sites. It is agreed that a protocol should be developed that further reflects the actual work process of Chiken in a clinical site, and that more detailed explanations of the execution process in a protocol should be helpful. The third WG focused on {"}standardization of checklist for both clinical sites and study sponsors{"}, covering the selection of clinical trial sites and execution of clinical trial agreements. It is also recognized that the checklist, apart from the original purpose of increasing the efficiency of the execution of clinical trials, is expected to be used as a training tool for beginners. After completing all tasks, a survey was made to assess this activity. Most of the members expressed positive opinions on this project, and the activity to develop a standardized checklist is on-going.",
keywords = "Checklist, Cooperative working group, Protocol, Source document",
author = "Mariko Taniguchi and Masayoshi Nakabayashi and Ichiro Oshiba and Satoshi Sugihara and Shuhei Nobutani and Yoshihiko Kobayashi and Kurumi Ohashi",
year = "2015",
language = "English",
volume = "46",
pages = "127--132",
journal = "Japanese Journal of Clinical Pharmacology and Therapeutics",
issn = "0388-1601",
publisher = "Japanese Society of Clinical Pharmacology and Therapeutics",
number = "3",

}

TY - JOUR

T1 - A progress report on cooperative working groups for improving efficiency of clinical trials for new drug development (Chiken)

AU - Taniguchi, Mariko

AU - Nakabayashi, Masayoshi

AU - Oshiba, Ichiro

AU - Sugihara, Satoshi

AU - Nobutani, Shuhei

AU - Kobayashi, Yoshihiko

AU - Ohashi, Kurumi

PY - 2015

Y1 - 2015

N2 - In April 2012, the Chiken(clinical study for drug application)Promotion Committee of Osaka Pharmaceutical Manufacturers Association(OPMA)and Osaka Clinical Research Collaborative Network(OCRCN)organized three Working Groups(WG)composed of clinical research coordinators(CRCs)and clinical research associates(CRAs) to discuss the improvement of the efficiency of Chiken execution. Each group had regular monthly meetings for one and a half years. The firstWG focused on the current understanding and treatment of "source data/document. " It is revealed that a so-called "work sheet" is widely used to record clinical data/comments in Chiken;data /comments are directly recorded on Case Report Forms(CRFs)only in around 50% of the cases. The second WG focused on the method to develop a more intelligible protocol in order to avoid misunderstanding of a protocol by clinical trial sites. It is agreed that a protocol should be developed that further reflects the actual work process of Chiken in a clinical site, and that more detailed explanations of the execution process in a protocol should be helpful. The third WG focused on "standardization of checklist for both clinical sites and study sponsors", covering the selection of clinical trial sites and execution of clinical trial agreements. It is also recognized that the checklist, apart from the original purpose of increasing the efficiency of the execution of clinical trials, is expected to be used as a training tool for beginners. After completing all tasks, a survey was made to assess this activity. Most of the members expressed positive opinions on this project, and the activity to develop a standardized checklist is on-going.

AB - In April 2012, the Chiken(clinical study for drug application)Promotion Committee of Osaka Pharmaceutical Manufacturers Association(OPMA)and Osaka Clinical Research Collaborative Network(OCRCN)organized three Working Groups(WG)composed of clinical research coordinators(CRCs)and clinical research associates(CRAs) to discuss the improvement of the efficiency of Chiken execution. Each group had regular monthly meetings for one and a half years. The firstWG focused on the current understanding and treatment of "source data/document. " It is revealed that a so-called "work sheet" is widely used to record clinical data/comments in Chiken;data /comments are directly recorded on Case Report Forms(CRFs)only in around 50% of the cases. The second WG focused on the method to develop a more intelligible protocol in order to avoid misunderstanding of a protocol by clinical trial sites. It is agreed that a protocol should be developed that further reflects the actual work process of Chiken in a clinical site, and that more detailed explanations of the execution process in a protocol should be helpful. The third WG focused on "standardization of checklist for both clinical sites and study sponsors", covering the selection of clinical trial sites and execution of clinical trial agreements. It is also recognized that the checklist, apart from the original purpose of increasing the efficiency of the execution of clinical trials, is expected to be used as a training tool for beginners. After completing all tasks, a survey was made to assess this activity. Most of the members expressed positive opinions on this project, and the activity to develop a standardized checklist is on-going.

KW - Checklist

KW - Cooperative working group

KW - Protocol

KW - Source document

UR - http://www.scopus.com/inward/record.url?scp=84937949037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937949037&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:84937949037

VL - 46

SP - 127

EP - 132

JO - Japanese Journal of Clinical Pharmacology and Therapeutics

JF - Japanese Journal of Clinical Pharmacology and Therapeutics

SN - 0388-1601

IS - 3

ER -